Table 1

Characteristics of patients who had an IS at baseline grouped by LDL-C levels

VariableLDL-C categoriesP value
1.80–2.59 (Reference)<1.401.40–1.792.60–2.993.00–4.89≥4.90
N249 33350 99167 587129 870270 79329 886
Age, years66.60 (±12.01)67.38 (±12.23)67.48 (±12.07)65.99 (±11.89)65.30 (±11.84)65.20 (±12.02)
Women (%)85 778 (34.40%)16 889 (33.12%)22 133 (32.75%)47 631 (36.68%)112 794 (41.65%)13 435 (44.95%)<0.01
NIHSS3 (2.6)3 (2.7)3 (2.6)3 (2.6)3 (2.6)4 (2.8)<0.01
Current Smoking, n (%)60 647 (24.32%)10 668 (20.92%)15 322 (22.67%)32 772 (25.23%)65 923 (24.11%)5500 (18.40%)<0.01
Alcohol intake, %59 613 (23.91%)11 745 (23.03%)15 922 (23.56%)31 268 (24.08%)62 197 (22.97%)6529 (21.85%)<0.01
Hypertension, %158 739 (63.67%)33 117 (64.95%)44 174 (65.36%)83 492 (64.29%)176 779 (65.28%)18 670 (62.47%)<0.01
Diabetes mellitus, %50 629 (20.31%)12 628 (24.77%)15 261 (22.58%)26 347 (20.29%)59 802 (22.08%)7171 (23.99%)<0.01
Dislipidemia, %15 600 (6.26%)3709 (7.27%)4753 (7.03%)8304 (6.39%)25 550 (9.44%)3897 (13.04%)<0.01
Previous atrial fib/flutter, %14 923 (5.99%)4371 (8.57%)5449 (8.06%)6031 (4.64%)10 086 (3.72%)1137 (3.80%)<0.01
Dual antiplatelet therapy, %97 860 (39.25%)17 697 (34.71%)25 393 (37.57%)53 069 (40.86%)109 214 (40.33%)9658 (32.32%)<0.01
Intravenous thrombolytic therapy, %15 135 (6.07%)3099 (6.08%)3861 (5.71%)8134 (6.26%)16 494 (6.09%)1452 (4.86%)<0.01
SBP, mm Hg148.76 (±22.55)144.93 (±22.59)146.56 (±22.24)150.73 (±22.84)152.52 (±23.22)151.28 (±24.14)<0.01
Body mass index, kg/m2 23.70 (±3.18)23.55 (±3.17)23.58 (±3.17)23.87 (±3.19)24.04 (±3.24)24.01 (±3.64)<0.01
  • LDL-C, low-density lipoprotein cholesterol; NIHSS, National Institutes of Health Stroke Scale; SBP, systolic blood pressure.